Successful Treatment with Imipenem/Cilastatin/Relebactam of a Polymicrobial Bacteremia due to Meropenem/Vaborbactam-Resistant KPC-Producing Klebsiella pneumoniae and Enterococcus faecalis
Mediterranean Journal of Hematology and Infectious Diseases · 30.04.2026 · 18 (1) · e2026037
DOI: 10.4084/mjhid.2026.037 ↗Kurz gefasst
Leserbrief in der Zeitschrift Mediterranean Journal of Hematology and Infectious Diseases, online erschienen am 30.04.2026. Verfasst von Federico Marzi und 5 weiteren Autor:innen. Beteiligte Einrichtung: UOC Medicina Interna, Ospedale S. Giovanni di Dio, Orbetello, Usl Toscana Sud Est, Italy. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Dear Editor, Carbapenemase-producing Klebsiella pneumoniae (KPC-Kp) remains a major global health challenge, associated with high mortality and limited therapeutic options [1,2]. Although novel β-lactam/β-lactamase inhibitor combinations (BL/BLI), such as meropenem/vaborbactam (M/V), have improved treatment outcomes, M/V-resistance is increasingly reported, often due to porin alterations or overexpression of blaKPC genes [2,4,7]. Imipenem/cilastatin/relebactam (IMI/REL) represents an alternative strategy, combining a carbapenem with a potent class A/C β-lactamase inhibitor that can restore activity against certain carbapenemase-producing strains [3–6].Herein, we describe the first documented case of successful treatment of a polymicrobial bloodstream infection caused by M/V-resistant but IMI/REL-susceptible KPC-Kp, with concomitant Enterococcus faecalis, in an elderly, frail patient.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- UOC Medicina Interna, Ospedale S. Giovanni di Dio, Orbetello, Usl Toscana Sud Est, Italy.
Zitieren
APA
Marzi, F., Alessandri, M., De Crescenzo, V., Del Vecchio, S., Radi, S., & Manini, M. (2026). Successful Treatment with Imipenem/Cilastatin/Relebactam of a Polymicrobial Bacteremia due to Meropenem/Vaborbactam-Resistant KPC-Producing Klebsiella pneumoniae and Enterococcus faecalis. Mediterranean Journal of Hematology and Infectious Diseases, 18(1), e2026037. https://doi.org/10.4084/mjhid.2026.037
Vancouver
Marzi F, Alessandri M, De Crescenzo V, Del Vecchio S, Radi S, Manini M. Successful Treatment with Imipenem/Cilastatin/Relebactam of a Polymicrobial Bacteremia due to Meropenem/Vaborbactam-Resistant KPC-Producing Klebsiella pneumoniae and Enterococcus faecalis. Mediterranean Journal of Hematology and Infectious Diseases. 2026;18(1):e2026037. doi:10.4084/mjhid.2026.037
BibTeX
@article{Marzi2026,
author = {Marzi, Federico and Alessandri, Mario and De Crescenzo, Veronica and Del Vecchio, Stefania and Radi, Simone and Manini, Maurizio},
title = {Successful Treatment with Imipenem/Cilastatin/Relebactam of a Polymicrobial Bacteremia due to Meropenem/Vaborbactam-Resistant KPC-Producing Klebsiella pneumoniae and Enterococcus faecalis},
journal = {Mediterranean Journal of Hematology and Infectious Diseases},
year = {2026},
volume = {18},
number = {1},
pages = {e2026037},
doi = {10.4084/mjhid.2026.037}
}
EUVIMED